Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.
about
Fludarabine in the treatment of chronic lymphocytic leukemia: a reviewAlemtuzumab for B-cell chronic lymphocytic leukemia.Fludarabine in Waldenstrom's macroglobulinemia.Role of fludarabine in hematological malignancies.Eradication of minimal residual disease with alemtuzumab in B-cell chronic lymphocytic leukemia (B-CLL) patients: the need for a standard method of detection and the potential impact of bone marrow clearance on disease outcome.Blood stem cell mobilization and collection in patients with lymphoproliferative diseases: practical issues.Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure.Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo OsseoContinuous infusion idarubicin and oral busulfan as conditioning for patients with acute myeloid leukemia aged over 60 years undergoing autologous stem cell transplantation.Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.Blood stem cell mobilization and collection in patients with chronic lymphocytic leukaemia: a nationwide analysis.
P2860
Q24645173-626474A4-3408-4EDE-A4F8-657CA1116470Q33380135-7F5A0B9E-07B6-41D8-AC90-60E8A7AF560CQ34351916-BA533E62-0C8D-460B-8DE7-E6CDEA90B866Q34571439-802B2D57-406D-4153-AF5B-4888B7C2CD5EQ36276344-94F9186F-810F-4E6D-9821-C1F351A76B26Q37053190-2721C59D-4521-4975-9126-1A4A86ADC39DQ41685138-00E21FA7-35BD-4772-A774-965615F1CAC6Q42592824-FC27B845-A0B6-4B51-B5AD-D4D1E398F0E5Q44982489-6DAB18C2-E646-4022-87DC-5C408185F698Q46389738-B700AEF8-3EAB-4990-AA33-1B147222839CQ46925369-1E844BD6-1FD3-426F-98C8-90CFB00F1158
P2860
Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Successful CD34+ cell mobiliza ...... al fludarabine and Campath-1H.
@en
Successful CD34+ cell mobiliza ...... al fludarabine and Campath-1H.
@nl
type
label
Successful CD34+ cell mobiliza ...... al fludarabine and Campath-1H.
@en
Successful CD34+ cell mobiliza ...... al fludarabine and Campath-1H.
@nl
prefLabel
Successful CD34+ cell mobiliza ...... al fludarabine and Campath-1H.
@en
Successful CD34+ cell mobiliza ...... al fludarabine and Campath-1H.
@nl
P2093
P2860
P356
P1433
P1476
Successful CD34+ cell mobiliza ...... al fludarabine and Campath-1H.
@en
P2093
A Tedeschi
B Scarpati
E Pungolino
G D'Avanzo
L Intropido
M Montillo
P2860
P2888
P356
10.1038/SJ.LEU.2403190
P577
2004-01-01T00:00:00Z
P5875
P6179
1029069363